Evidence map›Paper›PMID 31138564›Full record

ArticleAntimicrobial agents and chemotherapy2019

Lichtheimia corymbifera Colonization Leading to Pulmonary Infection Can Be Prevented with Liposomal Amphotericin B in a New Murine Model.

Thomas Brunet, Kévin Brunet, Grégory Jouvion, Estelle Cateau, Sandrine Marchand, Blandine Rammaert

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Thomas Brunet *INSERM U1070, Poitiers, France.
Kévin Brunet *INSERM U1070, Poitiers, France.
Grégory JouvionUnité de Neuropathologie Expérimentale, Institut Pasteur, Paris, France.
Estelle CateauUnité de Mycologie-Parasitologie, Département des Agents Infectieux, CHU Poitiers, Poitiers, France.
Sandrine MarchandINSERM U1070, Poitiers, France.ORCID 0000-0001-5279-6678
Blandine RammaertINSERM U1070, Poitiers, France blandine.rammaert.paltrie@univ-poitiers.fr.ORCID 0000-0002-9346-5848
Inserm · FRCentre Hospitalier Universitaire de Poitiers · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of pulmonary mucormycosis is constantly increasing, especially in hematological patients staying in high-efficiency particulate air-filtered rooms. Pulmonary inhalation of spores may occur outside the hospital, leading to invasive disease once patients received chemotherapies. We developed a new pulmonary mucormycosis mouse model mimicking the expected pathophysiology in human to study antifungal drugs. Naive mice were inoculated intratracheally with

Indexed as

Amphotericin BAnimalsAntifungal AgentsDisease Models, AnimalMaleMiceMice, Inbred BALB CMucormycosisRespiratory Tract InfectionsAmphotericin BAntifungal Agentsliposomal amphotericin Bantifungal agentsinvasive fungal diseaseMucoralesmucormycosisprophylaxis

Identifiers

PMID31138564
PMCPMC6658765
OpenAlexW2946340197

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.